Abstract

The article analyzes scientific publications of Ukrainian researchers from 2012 to 2022. Thirtytwo scientific publications from open resources and available printed publications were included in the list of analyzed articles. The search for articles was carried out by specifying the keywords “infectious peritonitis” and “feline infectious peritonitis” in search engines and scientific databases Google Scholar, Directory of Open Access Journals (DOAJ), Web of Science (WoS), Scopus, as well as the search service of the National Library of Ukraine named after V.I. Vernadskyi. The main criteria for the selection of the articles were their thematic focus on the study of infectious peritonitis of cats and the availability of the text of publications in the Internet in open access. At the beginning, the article analyzes the disease, theoretical and practical interventions in the world practice of diagnosis and treatment of feline infectious peritonitis (FIP). The article contains description of the biological basis of the disease and complications development of cats with feline infectious peritonitis. The results of the analysis indicate that the majority of publications in Ukraine were devoted to the postmortem study of changes in the internal organs of cats that died from feline infectious peritonitis. The obtained results indicate the development of multiple organ failure in cats. Practical treatment results described the experience of 13 cats, 12 of which received injectable forms of GS-441524. According to the correlation analysis, the use of laboratory research methods was not polymodal in the diagnosis of infectious peritonitis in cats, as indicated by prevalence of low and medium correlation between the use of laboratory research methods. In general, the results of the study indicate that the state of research of FIP in Ukraine during 2012 - 2022 was ascertaining but not experimental. Key words: feline infectious peritonitis, effusive fluid, pathomorphological changes, Rivalta test, FIP diagnosis, FIP treatment, GS-441524.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.